Khalid Shah

ASSOCIATE PROFESSOR, HARVARD MEDICAL SCHOOL 

Location: United States

Consulting Services


Areas Of Interest

Mesenchymal Stem Cells Stem Cell Transplantation Brain Neoplasms TNF-Related Apoptosis-Inducing Ligand Glioblastoma

Professional Narrative

Dr. Khalid Shah is the Vice Chair of Research for the Department of Neurosurgery at BWH and a Professor at Harvard Medical School. He directs The Center for Stem and Translational Immunotherapy and also a joint Center of Excellence in Biomedicine. He is also the Principal Faculty at Harvard Stem Cell Institute in Boston.

Dr. Khalid Shah and his team have pioneered major developments in the Stem Cell therapy field, successfully developing experimental models to understand basic cancer biology and therapeutic stem cells for cancer. These studies have been published in a number of very high impact journals like Nature NeurosciencePNASNature Reviews Cancer, JNCIStem Cells and Lancet Oncology. Dr. Khalid Shah’s stem cell work has caught the attention in the public domain and as such it has been highlighted in the media world-wide including features on BBC and CNN. Recently, Dr. Khalid Shah’s laboratory has reverse engineered cancer cells using CRISPR/Cas9 technology and utilized them as therapeutics to treat cancer. This work was published in journal Science Translation Medicine and highlighted world-wide including features on Scientific American, New York Times and NPR. Amongst Dr. Khalid Shah’s published works are two books featuring groundbreaking insights into stem cell therapies for cancer, Stem Cell Therapeutics for Cancer (Wiley-Blackwell), and Mesenchymal Stem Cells in Cancer Therapy (Elsevier).


Employment


Education


Referees


Publications


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :